{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1800430868",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1321492691"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/692812009",
    "http://id.who.int/icd/release/11/2024-01/mms/1800430868/other",
    "http://id.who.int/icd/release/11/2024-01/mms/1800430868/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1800430868",
  "code": "5C51.2",
  "source": "http://id.who.int/icd/entity/1800430868",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Disorders of glyoxylate metabolism"
  },
  "definition": {
    "@language": "en",
    "@value": "Primary hyperoxaluria, or oxalosis, is a rare metabolic disorder transmitted as an autosomal recessive disease, including both type 1, the most frequent, and type 2, extremely rare. Hyperoxaluria type 1 is due to a defect of the peroxysomal hepatic enzyme L-alanine: glyoxylate aminotransferase (AGT). Hyperoxaluria type 2 is extremely rare and is due to glycerate dehydrogenase deficiency."
  },
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/2072313921"
  ]
}